Homework Help is Here – Start Your Trial Now!
Science
Biology
1. What kind of disease is COVID-19? 2. What is the causative agent of COVID-192 3. How does a person get infected by COVID-19?

1. What kind of disease is COVID-19? 2. What is the causative agent of COVID-192 3. How does a person get infected by COVID-19?

Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
11th Edition
ISBN:9780134580999
Author:Elaine N. Marieb, Katja N. Hoehn
Publisher:Elaine N. Marieb, Katja N. Hoehn
Chapter1: The Human Body: An Orientation
Section: Chapter Questions
Problem 1RQ: The correct sequence of levels forming the structural hierarchy is A. (a) organ, organ system,...
See similar textbooks
icon
Related questions
Question
LENC 1. What kind of disease is COVID-19? 2. What is the causative agent of COVID-19? 3. How does a person get infected by COVID-19? 4. Whom would most likely spread COVID-19- an asymptomatic person or a symptomatic person? 5. When this article was published, what kind of treatment was only available? Today, what kind of preventive measure is available? 6. If you or the members of your family have not received such preventive measure, how do you protect yourself from this deadly COVID-19? 7. Recent studies show that many people who have been infected with the virus causing COVID-19 develop antibodies specific to this virus. What system or systems are involved in the production of antibodies? 8. With the preventive measure available to combat COVID-19, the term, "herd immunity" is often used. What is herd or population immunity? How is it achieved? 1970- An
Transcribed Image Text:LENC 1. What kind of disease is COVID-19? 2. What is the causative agent of COVID-19? 3. How does a person get infected by COVID-19? 4. Whom would most likely spread COVID-19- an asymptomatic person or a symptomatic person? 5. When this article was published, what kind of treatment was only available? Today, what kind of preventive measure is available? 6. If you or the members of your family have not received such preventive measure, how do you protect yourself from this deadly COVID-19? 7. Recent studies show that many people who have been infected with the virus causing COVID-19 develop antibodies specific to this virus. What system or systems are involved in the production of antibodies? 8. With the preventive measure available to combat COVID-19, the term, "herd immunity" is often used. What is herd or population immunity? How is it achieved? 1970- An
IV. SARS COV-2 and COVID-19: Where We Are Then and Now Directions: Read an excerpt from a Department of Health (DOH) article on COVID- 19 Disease. Then answer the questions that follow. BACKGROUND The novel coronavirus, SARS COV-2, first isolated in Wuhan City, Hubei province, in China last December 2019, has caused a global pandemic with staggering speed. As of June 30, 2020, there were more than > 10,000,000 COVID-19 cases worldwide, with more than 500,000 reported deaths... The situation in the Philippines has also rapidly evolved, with a single case identified last January 30, 2020, to over 200 cases by March 16, 2020... The clinical presentation of COVID-19 disease ranges from a mild common cold-like illness to a severe viral pneumonia leading to acute respiratory distress syndrome that is potentially fatal. Large, retrospective case series from China have shown that the elderly, those with comorbidities, and those with pneumonia are most at risk for severe disease (3- 6). The predominant mode of transmission remains person to person spread via respiratory droplets. The peak of infectiousness is just before or within 5 days of symptom onset. The main driver of transmission remains the symptomatic group although presymptomatics and asymptomatics may transmit the disease but to a lesser extent. Treatment is largely supportive, although in-vitro and early observational data regarding the off-label use of several re-purposed drugs, such as remdesivir, chloroquine, hydroxychloroquine, lopinavir-ritonavir and tocilizumab showed some promise. Various pharmacologic and nonpharmacologic interventions are being investigated in a clinical trial or given as compassionate use. Supportive care and intensive respiratory management remain the standard of care for COVID-19...
Transcribed Image Text:IV. SARS COV-2 and COVID-19: Where We Are Then and Now Directions: Read an excerpt from a Department of Health (DOH) article on COVID- 19 Disease. Then answer the questions that follow. BACKGROUND The novel coronavirus, SARS COV-2, first isolated in Wuhan City, Hubei province, in China last December 2019, has caused a global pandemic with staggering speed. As of June 30, 2020, there were more than > 10,000,000 COVID-19 cases worldwide, with more than 500,000 reported deaths... The situation in the Philippines has also rapidly evolved, with a single case identified last January 30, 2020, to over 200 cases by March 16, 2020... The clinical presentation of COVID-19 disease ranges from a mild common cold-like illness to a severe viral pneumonia leading to acute respiratory distress syndrome that is potentially fatal. Large, retrospective case series from China have shown that the elderly, those with comorbidities, and those with pneumonia are most at risk for severe disease (3- 6). The predominant mode of transmission remains person to person spread via respiratory droplets. The peak of infectiousness is just before or within 5 days of symptom onset. The main driver of transmission remains the symptomatic group although presymptomatics and asymptomatics may transmit the disease but to a lesser extent. Treatment is largely supportive, although in-vitro and early observational data regarding the off-label use of several re-purposed drugs, such as remdesivir, chloroquine, hydroxychloroquine, lopinavir-ritonavir and tocilizumab showed some promise. Various pharmacologic and nonpharmacologic interventions are being investigated in a clinical trial or given as compassionate use. Supportive care and intensive respiratory management remain the standard of care for COVID-19...
Expert Solution
steps

Step by step

Solved in 3 steps

SEE SOLUTIONCheck out a sample Q&A here
Blurred answer
Knowledge Booster
Substance abuse
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Recommended textbooks for you
Human Anatomy & Physiology (11th Edition)
Human Anatomy & Physiology (11th Edition)
Biology
ISBN:
9780134580999
Author:
Elaine N. Marieb, Katja N. Hoehn
Publisher:
PEARSON
Biology 2e
Biology 2e
Biology
ISBN:
9781947172517
Author:
Matthew Douglas, Jung Choi, Mary Ann Clark
Publisher:
OpenStax
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781259398629
Author:
McKinley, Michael P., O'loughlin, Valerie Dean, Bidle, Theresa Stouter
Publisher:
Mcgraw Hill Education,
Molecular Biology of the Cell (Sixth Edition)
Molecular Biology of the Cell (Sixth Edition)
Biology
ISBN:
9780815344322
Author:
Bruce Alberts, Alexander D. Johnson, Julian Lewis, David Morgan, Martin Raff, Keith Roberts, Peter Walter
Publisher:
W. W. Norton & Company
Laboratory Manual For Human Anatomy & Physiology
Laboratory Manual For Human Anatomy & Physiology
Biology
ISBN:
9781260159363
Author:
Martin, Terry R., Prentice-craver, Cynthia
Publisher:
McGraw-Hill Publishing Co.
Inquiry Into Life (16th Edition)
Inquiry Into Life (16th Edition)
Biology
ISBN:
9781260231700
Author:
Sylvia S. Mader, Michael Windelspecht
Publisher:
McGraw Hill Education
SEE MORE TEXTBOOKS